相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存:
240
- 英文名:
HLM006474
- CAS号:
353519-63-8
- 保质期:
2年
- 供应商:
北京百奥莱博科技有限公司
- 保存条件:
-20℃,有效期2年,溶入溶剂后-20℃
- 规格:
1mL(10mM)|5mg|10mg|50mg|100mg
特别提示:包括HLM006474在内,本公司的所有产品仅可用于科研实验,严禁用于临床医疗及其他非科研用途!
产品名称:HLM006474
英文名称:HLM006474
产品货号:M01769
产品规格:1mL(10mM)|5mg|10mg|50mg|100mg
HLM006474能抑制黑色素细胞增殖及在三维组织培养模型中的侵袭,还能干扰E2F活性。
注:本品仅可用于科研实验,严禁用于临床医疗及其他用途!
CAS号:353519-63-8
纯度:99.25%
分子式:C₂₅H₂₅N₃O₂
分子量:399.48
结构式:
储存条件:-20℃,有效期2年,溶入溶剂后-20℃请尽量在一个月内使用。
除了HLM006474,,我公司还供应以下相关产品:
| 货号 | 名称 | 规格 |
| BTN131226 | Karnovsky固定液 | 250mL |
| KFS244 | HRP标记链霉亲和素 | 10μl |
| KFS304 | 细胞自噬检测试剂盒(IF/ICC法),双色可选 | 100-200T |
| SY0607 | 嘌呤霉素盐酸盐 | 25mg |
| M00615 | 微管稳定剂(Epothilone D) | 2mg|5mg |
| M01590 | TAS-102 | 5mg|10mg|50mg|100mg |
| M01893 | IAPs拮抗剂(AT-406) | 1mL(10mM)|2mg|5mg|10mg|25mg|50mg |
| M01992 | Uridine triphosphate | 1mL(10mM)|10mg|50mg|100mg |
| M02531 | equol外消旋体((±)-Equol) | 1mL(10mM)|10mg|25mg|50mg|100mg|200mg |
| M03508 | Tedizolid | 1mL(10mM)|2mg|5mg|10mg|50mg |
| M04238 | Sodium copper chlorophyllin | 1mL(10mM)|1g |
| M04781 | Flurandrenolide | 1mL(10mM)|2mg|5mg|10mg|25mg |
| M05541 | Meprednisone | 1mL(10mM)|10mg|100mg |
| M06274 | J-147 | 1mL(10mM)|5mg|10mg|50mg |
| M06838 | 5-HT6受体拮抗剂 | 1mL(10mM)|5mg|10mg|25mg|50mg|100mg |
| M07145 | Kaempferide | 1mL(10mM)|5mg|10mg|50mg |
| M07216 | GLP-1(7-37) | 1mg|5mg|10mg|25mg |
| M07293 | 除草剂(Imazapic) | 1mL(10mM)|100mg|500mg |
| M07366 | 羰基探针(Biotin Hydrazide) | 1mL(10mM)|100mg |
| M07451 | TBHBA | 1mL(10mM)|5g |
| M07486 | 八氢姜黄素(Octahydrocurcumin) | 1mL(10mM)|5mg|10mg |
| M07571 | Cobalt phthalocyanine | 1g |
| M07719 | pGlu-Pro-Arg-MNA monoacetate | 1mL(10mM)|5mg|10mg|50mg |
| M07825 | Roxarsone | 1mL(10mM)|500mg |
| HR8234 | 细胞自噬检测试剂盒(MEC染色法) | 200T |
| BTN160181 | Houseby固定液 | 250ml |
| GL3082 | 酮粉试剂 | 15g |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验相关实验
Identification of Time-Dependent CYP Inhibitors Using Human Liver Microsomes (HLM)
Cytochrome P450s (CYPs) are responsible for the metabolism of a majority of marketed drugs and, as a consequence, alteration in CYP activity can result in clinically relevant drug-drug interactions (DDIs). Drugs that are time dependent
技术资料暂无技术资料 索取技术资料
HLM006474
¥380 - 3800









